ArticleFrontiers in pharmacology2025

Case report: Transformative potential of trastuzumab deruxtecan in the first line treatment for advanced HER2-mutated lung adenocarcinoma: a case report and clinical insights.

Guanbin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.